Key result
Preventive ICD terminates 3 VT episodes in a 21-year-old male with ARVC.
Why the study?
Arrhythmogenic right ventricular cardiomyopathy carries an increased risk for ventricular arrhythmias and sudden cardiac death, particularly in young athletes, emphasizing the importance of early detection and intervention.
Does ICD implantation and medical therapy prevent sudden cardiac death in a young athlete with ARVC?
Case Report (n=1)
No
Does ICD implantation and medical therapy prevent sudden cardiac death in a young athlete with ARVC?
Early multimodal diagnosis and preventive ICD implantation successfully terminated life-threatening ventricular arrhythmias in a young athlete with ARVC.
No takes yet. Share an insight, caveat, or question.
Supports ICD consideration in select young ARVC patients; leaves open need for prospective trials before wider adoption.
McClellan et al. (2025) conducted a case report in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (n=1). Implantable Cardioverter Defibrillator (ICD) and medical therapy was evaluated on Termination of ventricular tachycardia episodes. A preventive implantable cardioverter-defibrillator successfully terminated three episodes of ventricular tachycardia in a 21-year-old male with arrhythmogenic right ventricular cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: